Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,128 across all filing types
Latest filing 2024-03-05 Director's Dealing
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
113年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 葡萄王生技股份有限公司, including directors, independent directors, and senior management. It lists the number of shares held, pledged shares, and related ratios. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and pledges, which aligns with reporting on insider transactions or holdings. There is no indication of a full annual or interim report, audit report, or earnings release. The document is not a brief announcement but a detailed insider shareholding report. This fits best with the category of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives.
2024-03-05 Chinese
112年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment holdings and investment income related to overseas subsidiaries for a specific quarter (112年4季, which corresponds to Q4 of year 112 in the Taiwanese calendar). It includes details such as shareholding percentages, original investment amounts, investment balances, and recognized investment gains. The document is short (889 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. There is no indication that this is a full annual or interim report, nor is it a call transcript, management report, or other detailed report. It is a regulatory filing of investment information, likely submitted to a public information observatory (公開資訊觀測站). Given the nature and length, it fits best under Regulatory Filings (RNS) as a general regulatory disclosure that does not fit other specific categories.
2024-02-27 Chinese
112年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning the company's investments in mainland China. It includes specific financial data such as capital amounts, investment gains or losses, and cumulative investment figures. The document is relatively short (2295 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an announcement of a report publication, nor is it a certification or a brief summary. The content aligns with regulatory disclosure requirements about overseas investments, which typically fall under general regulatory filings. There is no indication that this is an annual report, interim report, earnings release, or any other specific report type. Therefore, the best classification is Regulatory Filings (RNS), as it is a regulatory disclosure document that does not fit other specific categories.
2024-02-27 Chinese
112年度財務比率
Fund Information / Factsheet Classification · 95% confidence The document contains a tabular summary of financial ratios and key financial metrics for the company 葡萄王 over the last three fiscal years (110年度, 111年度, 112年度). The data includes financial structure, debt ratios, liquidity ratios, operational efficiency, profitability, and cash flow metrics. The document is concise (1026 characters) and provides a summary of financial data rather than a full detailed report with financial statements or management discussion. There is no indication that this is a full Annual Report (10-K) or Interim Report (IR). It resembles a brief financial factsheet or summary of key financial data. Given the short length and summary nature, the best fitting category is Fund Information / Factsheet (FS).
2024-02-27 Chinese
112年度應收帳款周轉率
Fund Information / Factsheet Classification · 90% confidence The document is very short (283 characters) and contains financial ratios related to accounts receivable turnover and average collection days for two fiscal years (111 and 112). There is no indication of a full financial report, management discussion, or detailed financial statements. The content appears to be a brief financial metric update or a fact sheet rather than a comprehensive report. Given the brevity and nature of the data, it fits best as a Fund Information / Factsheet (FS) which typically provides brief summaries of key financial metrics.
2024-02-27 Chinese
112年度存貨週轉率
Regulatory Filings Classification · 95% confidence The document is very short (280 characters) and contains a brief table with inventory turnover rates and average sales days for two fiscal years (111 and 112). There is a note about explaining significant changes in inventory turnover rates. There is no detailed financial data, no comprehensive report, no management discussion, no regulatory certification, or any other detailed filing content. The document appears to be a brief disclosure or announcement of specific financial metrics rather than a full report or detailed filing. Given the brevity and nature, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2024-02-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.